Universe Pharmaceuticals Inc. Class A Ordinary Shares (UPC) Stock Price

UPCStock

$3.93−27.89%52W

Market Cap$19.75M

P/E—

PEG Ratio—

Div yield—

Beta1.76

UPC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)9.19%

Price vs S&P 500 (4W)-13.98%

VGM Score55.99

Book Value / Share (Quarterly)$99.64

P/TBV (Annual)0.04x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-28.07%

Cash Flow / Share (Quarterly)$-9.58

Price vs S&P 500 (YTD)-8.78%

Gross Margin (TTM)35.28%

Net Profit Margin (TTM)-20.56%

EPS (TTM)$-10.13

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-10.13

Revenue Growth (5Y)-11.68%

EPS (Annual)$-8.06

ROI (Annual)-5.62%

Gross Margin (Annual)35.28%

Net Profit Margin (5Y Avg)-2.90%

Cash / Share (Quarterly)$59.63

Revenue Growth QoQ (YoY)-28.96%

ROA (Last FY)-5.30%

Revenue Growth TTM (YoY)-22.32%

EBITD / Share (TTM)$-6.32

ROE (5Y Avg)-9.77%

Operating Margin (TTM)-19.02%

Cash Flow / Share (Annual)$-9.58

P/B Ratio0.35x

P/B Ratio (Quarterly)0.04x

Net Income / Employee (Annual)$-17,000

EV / Revenue (TTM)-0.26x

Net Interest Coverage (TTM)-20.99x

ROA (TTM)-4.90%

EPS Incl Extra (Annual)$-8.06

Current Ratio (Annual)4.07x

Quick Ratio (Quarterly)3.63x

3-Month Avg Trading Volume1.53M

52-Week Price Return-27.89%

Revenue / Employee (TTM)$82,700

Tangible BV / Share (Quarterly)$99.11

P/S Ratio (Annual)1.11x

Asset Turnover (Annual)0.26x

52-Week High$17.96

Operating Margin (5Y Avg)2.37%

EPS Excl Extra (Annual)$-8.06

CapEx CAGR (5Y)47.34%

26-Week Price Return19.09%

Quick Ratio (Annual)3.63x

13-Week Price Return-11.69%

Total Debt / Equity (Annual)0.16x

Current Ratio (Quarterly)4.07x

Enterprise Value$-4.59M

Revenue / Share Growth (5Y)32.77%

Asset Turnover (TTM)0.24x

Revenue / Employee (Annual)$82,700

Inventory Turnover (Annual)5.88x

Pretax Margin (Annual)-20.56%

Cash / Share (Annual)$59.63

3-Month Return Std Dev234.85%

Gross Margin (5Y Avg)44.09%

Net Income / Employee (TTM)$-17,000

ROE (Last FY)-6.54%

Net Interest Coverage (Annual)-20.99x

EPS Basic Excl Extra (Annual)$-8.06

P/FCF (TTM)4.11x

Receivables Turnover (TTM)1.38x

Total Debt / Equity (Quarterly)0.16x

EPS Incl Extra (TTM)$-10.13

Receivables Turnover (Annual)1.38x

ROI (TTM)-5.72%

P/S Ratio (TTM)1.11x

Pretax Margin (5Y Avg)1.52%

Revenue / Share (Annual)$39.17

Tangible BV / Share (Annual)$99.11

Price vs S&P 500 (52W)-43.42%

Year-to-Date Return3.15%

5-Day Price Return-4.84%

EPS Normalized (Annual)$-8.06

ROA (5Y Avg)-6.49%

Net Profit Margin (Annual)-20.56%

Month-to-Date Return-8.60%

Cash Flow / Share (TTM)$-2.26

EBITD / Share (Annual)$-6.53

Operating Margin (Annual)-19.02%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-7.99%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-10.13

P/TBV (Quarterly)0.04x

P/B Ratio (Annual)0.04x

Inventory Turnover (TTM)5.88x

Pretax Margin (TTM)-20.56%

Book Value / Share (Annual)$99.64

Price vs S&P 500 (13W)-14.37%

Beta1.76x

P/FCF (Annual)18.41x

Revenue / Share (TTM)$31.67

ROE (TTM)-6.60%

52-Week Low$2.00

vGradeA

gGradeD

mGradeB

vgmGradeC

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
UPCUniverse Pharmaceuticals Inc. Class A Ordinary Shares	A	D	B	1.1x	-22.3%	35.3%	—	$3.93
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Universe Pharmaceuticals Inc. Class A Ordinary Shares

Universe Pharmaceuticals Inc manufactures and distributes traditional Chinese medicine derivatives, biomedical drugs, medical instruments, and dietary supplements, with primary focus on chronic condition treatments and wellness products for elderly populations. The company's portfolio addresses age-related health conditions and longevity, supplemented by over-the-counter cold and flu medications.